| A4R | Accountability for reasonableness |
| AWP | Average wholesale price |
| BIA | Budget impact analysis |
| BTD | Better than dead |
| BWS | Best-worst scaling |
| CCA | Cost-consequence analysis |
| CEA | Cost-effectiveness analysis |
| CEAC | Cost-effectiveness acceptability curve |
| CER | Comparative effectiveness research |
| CMA | Cost-minimization analysis |
| COI | Conflict of interest |
| CQ | Clinical question |
| CSIMC | Central Social Insurance Medical Council (Chuikyo) [Japan] |
| CUA | Cost-utility analysis |
| CVM | Contingent caluation method |
| DALY | Disability-adjusted life year |
| DCE | Discrete choice experiment |
| DPC | Diagnosis Procedure Combination [Japan] |
| DRG | Diagnosis Related Groups |
| EOL | End-of-life |
| EVPI | Expected value of perfect information |
| EVPPI | Expected value of partially perfect information |
| EVSI | Expected value of sample information |
| HRQOL | Health-related quality of life |
| HTA | Health technology assessment |
| ICER | Incremental cost-effectiveness ratio |
| INB | Incremental net benefit |
| IPD | Individual participant data |
| LY | Life year |
| MCDA | Multi criteria decision analysis |
| MTC | Multiple treatment comparison |
| NHS | National Health Service |
| NMB | Net monetary benefit |
| NICE | The National Institute for Health and Care Excellence |
| PBM | Preference-based measure |
| PDPS | Per-Diem Payment System [Japan] |
| PE | Pharmacoeconomics |
| PPS | Prospective Payment System |
| PRO | Patient-reported outcome |
| PSA | Probabilistic sensitivity analysis |
| QALY | Quality-adjusted life year |
| QOL | Quality of life |
| RCT | Randomized controlled trial |
| SG | Standard gamble |
| SR | Systematic review |
| TA | Technology appraisal |
| TTO | Time trade-off |
| VAS | Visual analogue scale |
| VBP | Value-based pricing |
| VOI | Value of information |
| WTA | Willingness to accept |
| WTD | Worse than dead |
| WTP | Wilingness to pay |
Abbreviations
List of abbreviations in health technology assessment (alphabetic order)